|
Chair
Judith A. Eisen
Co-Chairs
David J. Biehl
(Real Estate)
Andrew J.
Schulson
(Finance)
Members
Daniel Alliance
Steven R. Antico
Suzanne M. Avena
David J. Biehl
Judith A. Eisen
B. Scott Higgins
Barbara D. Knothe
Sean P. Leyden
Doris L. Martin
Raymond P. Mulry
Alan H. Perzley
Karen L. Rodgers
Andrew J.
Schulson
Afsheen A. Shah
Christina Van Vort
Burton S. Weston
|
GW’s Finance and Real
Estate Practice Group provides advice on acquisition and
financing of capital assets, including real property,
equipment and major capital improvements. GW is
involved in all aspects of tax exempt and taxable
financing for corporate clients. GW has participated in
the issuance of more than $5 billion of tax exempt bonds
and tax exempt leases through various governmental and
commercial lenders. The Finance and Real Estate Practice
Group also advises on all phases of commercial and
residential real estate, including sale, exchange,
purchase, development, construction financing and
refinancing, leasing, syndication and local and federal
regulation. The
Finance and Real Estate Practice Group advises our
clients in the following representative areas:
- Borrower’s
representative before DASNY, MCFFA, HUD, IDAs and
other governmental non-taxable issuers and before
traditional commercial lender
- Architect (design)
and construction contracts
- Tax and disclosure
matters
- Equipment
acquisition and leasing, with both tax-exempt and
traditional equipment lessors
- Purchase, financing
and construction of medical, mixed-use and other
properties, with a special emphasis on the unique
needs of tax-exempt purchasers and borrowers.
- Lease and
construction, including medical offices, ambulatory
surgery centers, diagnostic and therapeutic
radiology facilities, cancer centers, diagnostic and
treatment centers and nursing homes, assisted living
facilities
- General real estate
and leasing
- Construction and
renovation of commercial and residential properties
- Real property tax
matters, including exemptions, abatements and
incentives for both tax-exempt and taxable owners
- Environmental
matters, including testing and remediation projects
The Finance, Real Estate
and Environmental Practice Group’s representation of
clients includes, among other things, the following:
- Tax-exempt and
taxable financing transactions for corporate,
institutional and other clients
- Representation
before governmental non-taxable issuers (e.g., DASNY,
HUD, IDA, New Jersey Health Care Facilities
Financing Authority) and before traditional
commercial lenders
- Architect (design),
construction and environmental consultant/contractor
contracts
- Environmental
liability transfer and/or buyout agreements
- Tax and disclosure
matters
- Accounts receivable
financing (sales, loans and securitizations)
- Special advice on
healthcare regulatory issues in varied financing
transactions
- Equipment
acquisition and leasing, with both tax-exempt and
traditional equipment lessors
- Purchase, financing
and construction of medical, mixed-use and other
properties, with a special emphasis on the unique
needs of tax-exempt purchasers and borrowers.
- Leasing and
construction, including medical offices, ambulatory
surgery centers, diagnostic and therapeutic
radiology facilities, cancer centers, diagnostic and
treatment centers and nursing homes, assisted living
facilities, adult homes, senior housing and other
long term residential care facilities
- General real estate
and leasing
- Construction and
renovation of commercial and residential properties
- Real property tax
matters, including exemptions, abatements and
incentives for both tax-exempt and taxable owners
and environmental conservation tax-abatement
easements
- Environmental due
diligence and compliance audits
- Negotiating clean-up
agreements with regulatory agencies and
environmental remediation contractors
- Obtaining liability
protective environmental insurance
- Environmental
agreements in sophisticated corporate and property
transactions
- Environmental
compliance advice (e.g., asbestos, lead-based paint,
underground storage tanks, mold, hazardous and
regulated medical waste)
|
|
